SHORT COMMUNICATION - EXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE IN HUMAN PLACENTA - AN IMMUNOHISTOCHEMICAL STUDY

被引:39
|
作者
MARZUSCH, K [1 ]
RUCK, P [1 ]
HORNY, HP [1 ]
DIETL, J [1 ]
KAISERLING, E [1 ]
机构
[1] UNIV TUBINGEN,INST PATHOL,D-72076 TUBINGEN,GERMANY
关键词
D O I
10.1016/0143-4004(95)90086-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Since human trophoblast undergoes extensive proliferation and exhibits invasive growth comparable to that of a malignant tumour, human placenta at various different stages of gestation was investigated immunohistochemically with the monoclonal antibody Ab-6 for expression of the p53 tumour suppressor gene. p53 protein was detected in the nuclei of a few trophoblastic cells, almost all belonging to the cytotrophoblast and only very few to the syncytiotrophoblast, in nearly all specimens investigated (first trimester 10/10, second trimester 5/5, third trimester 4/5). First trimester trophoblast exhibited increased expression of p53 protein in the juxtastromal areas of cytotrophoblast cell islands and columns, that is, in areas where high proliferative activity and increased expression of the epidermal growth factor receptor have been described in the literature. Staining was also occasionally seen in trophoblast invading the myometrium. It is most likely that immunohistochemically detectable expression of p53 protein in the trophoblast is due not to mutation of the gene, as in malignant tumours, but rather to up-regulation of the p53 tumour suppressor gene, which could be a mechanism for controlling trophoblast proliferation.
引用
收藏
页码:101 / 104
页数:4
相关论文
共 50 条
  • [21] THE P53 TUMOR-SUPPRESSOR GENE IS OVEREXPRESSED BUT NOT MUTATED IN HUMAN ATHEROSCLEROTIC TISSUE
    IACOPETTA, B
    WYSOCKI, S
    NORMAN, P
    HOUSE, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (02) : 399 - 402
  • [22] TUMOR-SUPPRESSOR P53 IS A DIRECT TRANSCRIPTIONAL ACTIVATOR OF THE HUMAN BAX GENE
    MIYASHITA, T
    REED, JC
    CELL, 1995, 80 (02) : 293 - 299
  • [23] IMMUNOHISTOCHEMICAL EXAMINATION OF TUMOR-SUPPRESSOR GENE P53 PRODUCT AND PYRIMIDINE DIMER IN SOLAR KERATOSIS
    TAGUCHI, M
    WATANABE, S
    SATO, Y
    KAMEYA, T
    MUNAKATA, N
    ISHIHARA, K
    NAKANE, PK
    HISATOME, H
    IKEDA, S
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (05) : 260 - 262
  • [24] IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CLINICAL ONCOLOGY
    CHANG, FJ
    SYRJANEN, S
    SYRJANEN, K
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 1009 - 1022
  • [25] THE P53 TUMOR-SUPPRESSOR GENE IN BREAST-CANCER
    ELLEDGE, RM
    ALLRED, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 39 - 47
  • [26] p53 tumor-suppressor gene: Clues to molecular carcinogenesis
    Wang, XW
    Harris, CC
    JOURNAL OF CELLULAR PHYSIOLOGY, 1997, 173 (02) : 247 - 255
  • [27] P53 AND RB TUMOR-SUPPRESSOR GENE ALTERATIONS IN RETINOBLASTOMA
    ITO, M
    MISHIMA, HK
    INAI, K
    ITO, T
    AKIYAMA, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (06) : 1329 - 1332
  • [28] CLINICAL-APPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE
    DIAMANDIS, EP
    CLINICA CHIMICA ACTA, 1995, 237 (1-2) : 79 - 90
  • [29] THE P53 TUMOR-SUPPRESSOR GENE AND ITS SIGNIFICANCE FOR DERMATOLOGY
    LUBBE, J
    KLEIHUES, P
    BURG, G
    HAUTARZT, 1994, 45 (11): : 741 - 745
  • [30] P53 TUMOR-SUPPRESSOR GENE IN CHRONIC MYELOGENOUS LEUKEMIA - A SEQUENTIAL STUDY
    ROVIRA, A
    URBANOISPIZUA, A
    CERVANTES, F
    ROZMAN, M
    VIVESCORRONS, JL
    MONTSERRAT, E
    ROZMAN, C
    ANNALS OF HEMATOLOGY, 1995, 70 (03) : 129 - 133